Cargando…

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA

Postoperative monitoring for patients with colorectal cancer (CRC) requires sensitive biomarkers that are associated with medical response and adjuvant therapy following surgery. Conventional tumor biomarkers [including carcinoembryonic antigen (CEA), CA19-9 and CA125] are widely used, but none of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiao, Huang, Tanxiao, Cheng, Fangsheng, Huang, Kaibing, Liu, Ming, He, Wan, Li, Mingwei, Zhang, Xiaoni, Xu, Mingyan, Chen, Shifu, Xia, Ligang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835910/ https://www.ncbi.nlm.nih.gov/pubmed/29541205 http://dx.doi.org/10.3892/ol.2018.7837

Ejemplares similares

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
por: Xu, Ruilian, et al.
Publicado: (2018)

GeneFuse: detection and visualization of target gene fusions from DNA sequencing data
por: Chen, Shifu, et al.
Publicado: (2018)

Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy
por: Cao, Hua, et al.
Publicado: (2020)

MutScan: fast detection and visualization of target mutations by scanning FASTQ data
por: Chen, Shifu, et al.
Publicado: (2018)

AfterQC: automatic filtering, trimming, error removing and quality control for fastq data
por: Chen, Shifu, et al.
Publicado: (2017)

Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
por: Wang, Feng, et al.
Publicado: (2022)

Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients
por: Nicolazzo, Chiara, et al.
Publicado: (2020)

Case Report: Cetuximab in Combination With Chemotherapy for the Treatment of Multifocal Hepatic Metastases From Colorectal Cancer Guided by Genetic Tests
por: Qiu, Chunhui, et al.
Publicado: (2021)

Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer
por: He, Wan, et al.
Publicado: (2022)

Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
por: Ng, Sarah B., et al.
Publicado: (2017)

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
por: Zhou, Jiaolin, et al.
Publicado: (2016)

Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data
por: Chen, Shifu, et al.
Publicado: (2019)

Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients
por: Kazemifard, Nesa, et al.
Publicado: (2019)

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
por: Reece, Mifanwy, et al.
Publicado: (2019)

Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis
por: Peng, Honghua, et al.
Publicado: (2021)

Plasma β-Amyloid Levels Associated With Structural Integrity Based on Diffusion Tensor Imaging in Subjective Cognitive Decline: The SILCODE Study
por: Wang, Xiaoni, et al.
Publicado: (2021)

The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients
por: Wu, Guowu, et al.
Publicado: (2022)

Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
por: Allegretti, Matteo, et al.
Publicado: (2020)

Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review
por: Li, Xiaobin, et al.
Publicado: (2020)

Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients
por: Galbiati, Silvia, et al.
Publicado: (2021)

Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer
por: Egyud, Matthew, et al.
Publicado: (2018)

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
por: Mack, Elisabeth K. M., et al.
Publicado: (2022)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
por: Lin, Wu-Hao, et al.
Publicado: (2021)

Using circulating tumor DNA to monitor myelodysplastic syndromes status
por: Zhao, Pan, et al.
Publicado: (2019)

LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer
por: Nagai, Yuzo, et al.
Publicado: (2017)

Clinical implications of perineural invasion in patients with colorectal cancer
por: Hu, Gang, et al.
Publicado: (2020)

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
por: Busser, Benoit, et al.
Publicado: (2017)

Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer
por: Takayama, Yuji, et al.
Publicado: (2018)

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
por: Berger, Andreas W., et al.
Publicado: (2017)

Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
por: Fu, Yun, et al.
Publicado: (2021)

Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer
por: Zhao, Qi, et al.
Publicado: (2022)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma
por: Sun, Li, et al.
Publicado: (2021)

Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series
por: Ji, Hongyan, et al.
Publicado: (2021)

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis
por: Zhang, Lei, et al.
Publicado: (2019)

Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hjmuibu6e0hfqfcfo8e2aa8vhk